H
ELVETICA
CHIMICA
ACTA – Vol. 88 (2005)
2829
General Procedure for the Preparation of 1,4-Anhydro Sugars by Microwave Chemistry. Galactopyranoside
i.e., (1a–1c) (0.1–0.4 mmol) and FeCl (10–30%) were dissolved in MeCN (5 ml). Microwave heating was per-
3
formed in a sealed tube for 30 min at 908. The maximum power of microwave was set to 150 W, and the power
was controlled during the heating to keep 908. After microwave irradiation and cooling, the mixture was filtered
over a short silica gel pad and concentrated. The crude product was purified by flash silica-gel column chroma-
tography (FC) with mixtures of AcOEt and hexane as eluent.
General Procedure for Ring Opening of 1,4-Anhydro Sugars: Pentenyl 2,3,6-Tri-O-benzyl-
side (5c). 1,4-Anhydrogalactose 2a (135 mg, 0.31 mmol) and pent-4-en-1-ol (134 mg, 1.6 mmol) were dissolved
in CH Cl (3 ml) and cooled to 08. After 10 min, TfOH (30 ml, 51 mg, 0.34 mmol) was added, then the soln. was
allowed to warm slowly to r.t. The completion of the reaction was checked by TLC, then the mixture was neu-
tralized with Et N and concentrated in vacuo. The residue was purified by FC (silica gel; AcOEt/hexane 2 :5) to
D-galactofurano-
2
2
3
yield 5c (130 mg, 81%) as a colorless syrup.
Methyl 2,3-Di-O-benzoyl-6-O-benzyl-a-
D-galactopyranoside (1b). The selective ring-opening reaction of
4
2
,6-O-benzylidene acetal was performed according to the method mentioned above. The ring opening of methyl
,3-di-O-benzoyl-4,6-O-benzylidene-a- -galactopyranose (1.0 g, 2.0 mmol) afforded 0.73 g (72%) of 1b. TLC
0.35. [a] =+109.0 (c=2.4, CHCl
): 8.01–7.97 (m, 4 H); 7.52–7.47 (m, 2 H); 7.38–7.32 (m, 9 H); 5.74–5.66 (m, 2 H);
D
1
(
AcOEt/hexane 2 :5): R
f
D
3 3
). IR (CHCl ) 3008, 1721, 1452, 1281, 1107. H-
NMR (300 MHz, CDCl
3
5
3
1
.22 (d, J=2.7, 1 H); 4.64 (d, J=12.0, 1 H); 4.59 (d, J=11.7, 1 H); 4.45 (s, 1 H); 4.15 (t, J=4.5, 1 H); 3.88–
.79 (m, 2 H); 3.43 (s, 3 H); 3.17–3.13 (s, 1 H). C-NMR (75 MHz, CDCl ): 166.3; 166.1; 137.7; 133.5; 133.4;
3
1
3
30.1; 129.7; 129.7; 128.8; 128.6; 128.6; 128.1; 128.0; 97.9; 74.1; 71.3; 70.3; 69.5; 69.3; 68.5, 55.8. HR-MALDI-
+
þ
MS: 515.1684 ([M+Na] , C28
H
28NaO , calc. 515.1682).
8
1
,4-Anhydro-2,3-di-O-benzoyl-6-O-benzyl-b-
D
-galactopyranose (2b). Compound 1b (200 mg, 0.40 mmol)
0.65. [a] =+159.0 (c=1.8, CHCl ). IR (CHCl
): 8.10–8.05 (m, 4 H); 7.64–7.56 (m, 2 H); 7.49–7.43 (m, 4
H); 7.36–7.28 (m, 5 H); 5.95 (d, J=2.4, 1 H); 5.17 (d, J=1.5, 1 H); 5.12 (m, 1 H); 4.82 (d, J=1.5, 1 H); 4.58
d, J=12.0, 1 H); 4.54 (d, J=12.0, 1 H); 4.09 (dd, J=7.2, 6.0, 1 H); 3.48 (dd, J=9.6, 5.7, 1 H); 3.42 (dd,
afforded 23 mg (12%) of 2b. TLC (AcOEt/hexane 2 :5): R
032, 1722, 1271, 1113. H-NMR (300 MHz, CDCl
3
f
D
3
3
)
1
3
(
1
3
J=9.6, 7.2, 1 H). C-NMR (75 MHz, CDCl
28.3; 127.7; 127.7; 98.4; 81.6; 81.3; 77.2; 74.4; 73.6; 69.6. HR-MALDI-MS: 483.1420 ([M+Na] , C27
calc. 483.1420).
,4-Anhydro-2,3-di-O-benzyl-6-O-[(tert-butyl)dimethylsilyl]-b-
benzyl-6-O-[(tert-butyl)dimethylsilyl]-a- -galactopyranoside (1c) (170 mg, 0.35 mmol) afforded 40 mg (25%)
of 2c. TLC (AcOEt/hexane 2 :5): R 0.80. [a] =+42.8 (c=1.2, CHCl ). IR (CHCl ) 2930, 1454, 1256, 1109,
): 7.40–7.31 (m, 10 H); 5.36 (d, J=4.2, 1 H); 4.69 (d, J=11.4, 1 H); 4.56 (d,
J=11.7, 1 H); 4.54 (d, J=11.7, 1 H); 4.49 (d, J=12.0, 1 H); 4.16–4.14 (m, 1 H); 4.09–4.02 (m, 1 H); 3.92
3
): 165.8; 165.7; 137.5; 133.4; 133.4; 129.8; 129.7; 129.0; 128.4;
+
þ
1
H
24NaO ;
7
1
D-galactopyranose (2c). Methyl 2,3-di-O-
D
f
D
3
3
1
1
007. H-NMR (300 MHz, CDCl
3
1
3
(
ddd, J=10.8, 6.0, 1.5, 1 H); 3.72 (t, J=10.8, 1 H); 0.90 (s, 9 H); 0.12 (s, 3 H); 0.09 (s, 3 H). C-NMR (75
MHz, CDCl ): 137.7; 137.5; 128.4; 128.4; 128.1; 128.0; 127.8; 127.7; 97.0; 85.5; 82.0; 81.0; 72.5; 71.3; 66.2;
3
+
+
6
3.4; 25.7; 17.9; À4.6; À4.6. HR-MALDI-MS: 479.2232 ([M+Na] , C26
,4-Anhydro-2,3-di-O-benzyl-a- -arabinopyranose (4). Methyl 2,3-di-O-benzyl-a-
12 mg, 0.32 mmol) afforded 16 mg (16%) of 4. TLC (AcOEt/hexane 2 :5): R 0.30. [a]
): 7.38–7.31 (m, 10 H); 5.53 (d,
J=2.4, 1 H); 4.71 (dd, J=4.5, 1.5, 1 H); 4.61 (d, J=11.7, 1 H); 4.53 (d, J=11.7, 1 H); 4.52 (s, 2 H); 3.86–3.84
H
36NaO
5
Si ; calc. 479.2230).
-arabinopyranose (3a;
=À65.1 (c=1.6,
1
D
D
1
f
D
1
3 3 3
CHCl ). IR (CHCl ) 2900, 1725, 1454, 1115. H-NMR (300 MHz, CDCl
1
3
(
3
m, 1 H); 3.63 (dd, J=7.2, 3.9, 1 H); 3.58 (d, J=7.2, 1 H); 3.55 (d, J=1.5, 1 H). C-NMR (75 MHz, CHCl ):
1
37.3; 128.4; 128.0; 127.9; 127.8; 127.8; 98.5; 87.4; 82.9; 80.0; 72.4; 71.0; 65.5. HR-MALDI-MS: 335.1261
+
þ
([M+Na] , C19
H
20NaO ; calc. 335.1259).
4
Methyl 2,3,6-Tri-O-benzyl-a-
afforded 15 mg (24%) of 5aa and 33 mg (50%) of 5ab (a/b 32 :68). TLC (AcOEt/hexane 2 :5): R
D
-galactofuranoside (5aa). The ring opening with MeOH (45 mg, 1.4 mmol)
0.30 (5aa),
) 2928, 1453, 1364, 1108. H-NMR (300 MHz, CHCl ):
.37–7.26 (m, 15 H); 4.72 (d, J=11.4, 1 H); 4.70 (d, J=4.2, 1 H); 4.62 (s, 2 H); 4.57 (d, J=11.4, 1 H); 4.55 (d,
f
1
0
7
.20 (5ab). [a]
D
=+22.4 (c=2.0, CHCl
3
). IR (CHCl
3
3
J=12.3, 1 H); 4.50 (d, J=12.0, 1 H); 4.34 (dd, J=7.2, 6.3, 2 H); 4.11–4.05 (m, 2 H); 3.81–3.75 (m, 1 H); 3.48
1
3
(
3
d, J=6.0, 1 H); 3.40 (s, 3 H); 2.79 (d, J=6.9, 1 H). C-NMR (75 MHz, CDCl ): 137.9; 137.8; 137.3; 128.4;
1
28.3; 128.2; 128.1; 128.0; 127.7; 127.7; 127.5; 101.8; 84.3; 81.5; 81.1; 73.3; 72.7; 72.5; 70.9; 55.9. HR-MALDI-
+
þ
MS: 487.2098 ([M+Na] ; C30
H
34NaO ; calc. 487.2097).
7
Methyl 2,3,6-Tri-O-benzyl-b-
D
-galactofuranoside (5ab). [a]
454, 1362, 1101, 1042. H-NMR (300 MHz, CHCl ): 7.36–7.26 (m, 15 H); 4.95 (s, 1 H); 4.60–4.46 (m, 6 H);
.13 (dd, J=5.7, 3.3, 2 H); 4.05 (dd, J=6.6, 2.1, 1 H); 3.98 (dd, J=2.4, 0.9, 1 H); 3.91 (td, J=6.0, 3.6, 1 H);
D
=À51.0 (c=1.9, CHCl
3 3
). IR (CHCl ) 2923,
1
1
4
3